Cargando…

Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy

Autophagy, a self-eating machinery, has been reported as an adaptive response to maintain metabolic homeostasis when cancer cells encounter stress. It has been appreciated that autophagy acts as a double-edge sword to decide the fate of cancer cells upon stress factors, molecular subtypes, and micro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ying-Ying, Feun, Lynn G., Thongkum, Angkana, Tu, Chiao-Hui, Chen, Shu-Mei, Wangpaichitr, Medhi, Wu, Chunjing, Kuo, Macus T., Savaraj, Niramol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486118/ https://www.ncbi.nlm.nih.gov/pubmed/28629173 http://dx.doi.org/10.3390/ijms18061297

Ejemplares similares

Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma
por: Wu, Chunjing, et al.
Publicado: (2021)

BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
por: Li, Ying-Ying, et al.
Publicado: (2016)

Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
por: Savaraj, Niramol, et al.
Publicado: (2015)

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
por: Wu, Chunjing, et al.
Publicado: (2005)

Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to arginine deprivation
por: Li, Ying‐Ying, et al.
Publicado: (2017)

Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
por: Wangpaichitr, Medhi, et al.
Publicado: (2017)

Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes
por: Kuo, Macus Tien, et al.
Publicado: (2010)

The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma
por: Thongkum, Angkana, et al.
Publicado: (2017)

N′(1),N′(3)-Dimethyl-N′(1),N′(3)-bis(phenylcarbonothioyl) Propanedihydrazide (Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer Cells through Reactive Oxygen Species (ROS)
por: Wangpaichitr, Medhi, et al.
Publicado: (2009)

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
por: Savaraj, Niramol, et al.
Publicado: (2007)

Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration
por: Wangpaichitr, Medhi, et al.
Publicado: (2021)

Targeting the Proline–Glutamine–Asparagine–Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy
por: Kuo, Macus Tien, et al.
Publicado: (2021)

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
por: Feun, Lynn G, et al.
Publicado: (2018)

Procollagen-Like Protein as a Molecular Target in the Treatment of Primary Brain Tumor
por: Wangpaichitr, Medhi, et al.
Publicado: (2002)

Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer
por: Wu, Chunjing, et al.
Publicado: (2023)

Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation
por: Long, Yan, et al.
Publicado: (2016)

Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors
por: Kuo, Macus Tien, et al.
Publicado: (2019)

Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know
por: Bhatia, Shivank, et al.
Publicado: (2016)

Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression
por: Tsai, Wen-Bin, et al.
Publicado: (2017)

The pros and cons of autophagic flux among herpesviruses
por: Grose, Charles, et al.
Publicado: (2015)

Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer
por: Wangpaichitr, M, et al.
Publicado: (2017)

Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals
por: Liang, Zheng Dong, et al.
Publicado: (2013)

Pros & Cons
por: Herr, Yeek
Publicado: (2011)

Supercollider: Pros and cons
Publicado: (1993)

Circumcision: Pros and cons
por: Burgu, Berk, et al.
Publicado: (2010)

The pros and cons of degeneracy
por: Goaillard, Jean-Marc, et al.
Publicado: (2014)

Pros and Cons of Focal Therapy for Localised Prostate Cancer
por: Mearini, Luigi, et al.
Publicado: (2011)

The Pros and Cons of Percutaneous Coronary Intervention in Patients With Cancer
por: Giri, Jay, et al.
Publicado: (2019)

Medical dramas – the pros and the cons
por: Aboud, Khalid Al
Publicado: (2012)

Pros and cons of student journals
por: Aboshady, Omar Ali, et al.
Publicado: (2016)

Rheumatology in Greece: pros and cons
por: Moutsopoulos, Haralampos M.
Publicado: (2020)

Veterinary nanomedicine: Pros and cons
por: Jafary, Fariba, et al.
Publicado: (2022)

Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer
por: Sclafani, Francesco, et al.
Publicado: (2021)

Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies
por: Irrera, Natasha, et al.
Publicado: (2021)

Nanoparticles: Health Effects—Pros and Cons
por: Gwinn, Maureen R., et al.
Publicado: (2006)

Finemet versus ferrite: Pros and cons
por: Ng, K Y, et al.
Publicado: (1999)

Cervical disc arthroplasty: Pros and cons
por: Moatz, Bradley, et al.
Publicado: (2012)

Pros and cons of phospholipid asymmetry in erythrocytes
por: Sathi, Aiswarya, et al.
Publicado: (2014)

Ovarian Stem Cells—the Pros and Cons
por: Evron, Ayelet, et al.
Publicado: (2013)

Endoscopist-Directed Propofol: Pros and Cons
por: Kim, Eun Hye, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ab05tqsicp18tv15mgigfr5eed